Clinical Trials Logo

Filter by:
NCT ID: NCT03774914 Terminated - Multiple Sclerosis Clinical Trials

LEMTRADA Pregnancy Registry in Multiple Sclerosis

Start date: September 1, 2015
Phase:
Study type: Observational [Patient Registry]

Primary Objective: The primary goal of this registry is to assess the risk of spontaneous abortion in prospective enrolled women exposed to LEMTRADA for multiple sclerosis. Secondary Objective: The secondary goals of this registry is to assess maternal, fetal and infant outcome in women with multiple sclerosis, exposed to LEMTRADA.

NCT ID: NCT03773367 Active, not recruiting - Clinical trials for Resectable Gastric and Gastroesophageal Junction Adenocarcinoma

Irinotecan-based Triplet (FOLFOXIRI) as Perioperative Treatment in Resectable Gastric and Gastroesophageal Junction Adenocarcinoma.

INTENSE
Start date: December 14, 2018
Phase: Phase 2
Study type: Interventional

In this clinical trial, patients with gastric and gastroesophageal junction adenocarcinoma will be included. Treatment with curative intent will be given with chemotherapy for 4 cycles with fluorouracil, oxaliplatin and irinotecan preoperatively followed by surgery, and then additionally 4 cycles of the same chemotherapy postoperatively. The standard treatment today is preoperative treatment with fluorouracil and oxaliplatin pre-and postoperatively. The rationale for this trial is, that the addition of irinotecan might improve treatments results.

NCT ID: NCT03773211 Completed - Clinical trials for Delayed Graft Function

Renaparin® in Kidney Transplantation

Start date: February 14, 2019
Phase: Phase 1
Study type: Interventional

This study evaluates the safety and tolerability of Renaparin in adult patients receiving a deceased donor kidney treated ex-vivo with Renaparin prior to transplantation. Half the patient group will receive a kidney treated with Renaparin, while the other half of the patient group will receive a kidney treated with placebo.

NCT ID: NCT03772028 Recruiting - Ovarian Cancer Clinical Trials

Primary Cytoreductive Surgery With or Without Hyperthermic Intraperitoneal Chemotherapy (HIPEC)

OVHIPEC-2
Start date: January 1, 2020
Phase: Phase 3
Study type: Interventional

stage III epithelial ovarian cancer randomizing between primary cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy

NCT ID: NCT03771950 Not yet recruiting - Clinical trials for Traumatic Brain Injury

Early Team Based Neuro-rehabilitation After Traumatic Brain Injury - a Pilot Study

Start date: January 1, 2019
Phase: N/A
Study type: Interventional

The aim is to evaluate the study design, procedure and measurements in a randomised controlled pilot study.

NCT ID: NCT03770962 Completed - Clinical trials for Pelvic Floor Disorders

One Plus One Equals Two, Will That do?

Oneplus
Start date: December 10, 2018
Phase: N/A
Study type: Interventional

A new clinical practice to reduce perineal trauma has been adopted by many maternity wards in Sweden. This practice involves collegial midwifery assistance during the second stage of labor and the birth of the baby. The midwife responsible for the birth is the primary carer of the woman and the second midwife observes the birth or assists the primary midwife if asked to. The hypothesis is that the presence and support of an extra midwife will reduce severe perineal trauma (trauma to the anal sphincter (OASI)). The objective of this trial is to evaluate whether collegial midwifery assistance during the second stage reduces perineal trauma grade III-IV.

NCT ID: NCT03770078 Completed - Ileostomy - Stoma Clinical Trials

Assessment of New Enhanced Ostomy Device in Real-life Settings in Subjects Having a Stoma

Start date: November 12, 2018
Phase: N/A
Study type: Interventional

The study investigates the performance of a new adhesive with regard to the skin condition

NCT ID: NCT03768180 Completed - Clinical trials for Infective Endocarditis of Aortic Valve

Infective Endocarditis After TAVR

INTENSE
Start date: January 1, 2018
Phase:
Study type: Observational

This study aims at studying the frequency of infective endocarditis after transcatheter aortic valve replacement/implantation

NCT ID: NCT03767075 Recruiting - Clinical trials for Advanced Solid Tumor

A Modular Multi-Basket Trial to Improve Personalized Medicine in Cancer Patients (Basket of Baskets)

BoB
Start date: December 10, 2018
Phase: Phase 2
Study type: Interventional

The global objective of this Basket of Basket study is to evaluate the antitumor activity of each matched therapies that will be evaluated through the study in small molecularly selected populations. The objective of module 1 wil be to determine the overall response rate (ORR) at 12 weeks by Response Evaluation Criteria in Solid Tumors (RECIST) 1.1 of atezolizumab in each of the arms of the module. All patients in genomically selected populations will receive atezolizumab 1200 mg IV every 3 weeks. The objective of module 2 wil be to determine the overall response rate (ORR) at 16 weeks by Response Evaluation Criteria in Solid Tumors (RECIST) 1.1 of futibatinib in each of the arms of the module. All patients in genomically selected populations will receive will receive futibatinib, 20 mg, once daily (QD) in 28-day cycles. The objective of module 3 wil be to determine the overall response rate (ORR) at 12 weeks by Response Evaluation Criteria in Solid Tumors (RECIST) 1.1 of amivantamab in each of the arms of the module. All patients in genomically selected populations will receive amivantamab 1050 mg intravenously (IV) for body weight < 80 kg and 1400 mg for body weight >= 80 kg mg once weekly in Cycle 1 (with a split dose on Days 1-2) and then every 2 weeks in subsequent cycles (28-day cycles).

NCT ID: NCT03766581 Completed - Clinical trials for Acute Ischemic Stroke

A Study on BMS-986177 for the Prevention of a Stroke in Patients Receiving Aspirin and Clopidogrel

AXIOMATIC-SSP
Start date: January 27, 2019
Phase: Phase 2
Study type: Interventional

The purpose of this clinical study is to determine whether the addition of an oral Factor XIa Inhibitor to Aspirin and Clopidogrel is more effective than standard therapy in secondary stroke prevention.